Calcific aortic valve disease lacks drug treatments, with current guidelines focusing on invasive surgical or interventional modalities for advanced disease.
Calcific aortic valve diseaselack of drug treatmentCalcific aortic valve disease (CAVD) represents one of the most prevalent cardiovascular diseases in the aging population. 1 It can progress to relevant aortic stenosis and accounts for significant cardiac morbidity and mortality.Current European guidelines on the treatment of aortic valve stenosis 2 focus on surgical or interventional treatment modalities that comprise valvular repair or replacement.Although very effective, those modalities confer obvious risk and morbidity given their invasiveness.Additionally, they are directed against clinically, functionally and/or morphologically advanced CAVD.
Wang et al. (2025) conducted a review in Calcific aortic valve disease (CAVD). Calcific aortic valve disease lacks drug treatments, with current guidelines focusing on invasive surgical or interventional modalities for advanced disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: